Population Pharmacokinetics of Obinutuzumab (GA101) in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin’s Lymphoma and Exposure–Response in CLL

CPT: Pharmacometrics and Systems Pharmacology - United States
doi 10.1038/psp.2014.42
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

DNA Methylation Signatures in Chronic Lymphocytic Leukemia (CLL)

Science-Business eXchange
2012English

Cd160 Expression in B Chronic Lymphocytic Leukemia (B-Cll.).

International Journal of Advanced Research
2017English

Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)

Current Hematologic Malignancy Reports
Cancer ResearchOncologyHematology
2016English

Bendamustine (B), Followed by Obinutuzumab (G) and Venetoclax (A) in Patients With Chronic Lymphocytic Leukemia (Cll): Cll2-Bag Trial of the German CLL Study Group (Gcllsg)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Venetoclax–Obinutuzumab Elicits High Response Rates in CLL

Cancer Discovery
Oncology
2019English

The PI3Kδ INHIBITOR ME-401 ± RITUXIMAB IN RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL), CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), AND SMALL LYMPHOCYTIC LYMPHOMA (SLL)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Health Economics and Outcomes Data Requirements in Indolent Non Hodgkins Lymphoma (Inhl) and Chronic Lymphocytic Leukemia (Cll) From United States Payer Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Mp12: Cryoglobulinemia in a Patient With Chronic Lymphocytic Leukemia (Cll)– A Case Report and Review of Literature of Renal Involvement in CLL

Journal of Investigative Medicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

Transcend CLL 004: Minimal Residual Disease After Lisocabtagene Maraleucel in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy